BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11585118)

  • 21. Effects of treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of metalloproteinases and their ability to predict response to treatment.
    Haerian A; Adonogianaki E; Mooney J; Manos A; Kinane DF
    J Clin Periodontol; 1996 Feb; 23(2):83-91. PubMed ID: 8849843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GCF levels of MMP-3 and MMP-8 following placement of bioresorbable membranes.
    Said S; Mohd H; Sander L; Rönkä H; Sorsa T; Kinane DF
    J Clin Periodontol; 1999 Nov; 26(11):757-63. PubMed ID: 10589813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients.
    Pawar DD; Mehta DS
    J Investig Clin Dent; 2015 May; 6(2):118-24. PubMed ID: 24357595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review.
    Sculean A; Schwarz F; Becker J; Brecx M
    Med Princ Pract; 2007; 16(3):167-80. PubMed ID: 17409750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine (interleukin-1beta) and MMP levels in gingival crevicular fluid after use of platelet-rich fibrin or connective tissue graft in the treatment of localized gingival recessions.
    Eren G; Tervahartiala T; Sorsa T; Atilla G
    J Periodontal Res; 2016 Aug; 51(4):481-8. PubMed ID: 26447636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis.
    Leppilahti JM; Hernández-Ríos PA; Gamonal JA; Tervahartiala T; Brignardello-Petersen R; Mantyla P; Sorsa T; Hernández M
    J Clin Periodontol; 2014 Apr; 41(4):348-56. PubMed ID: 24382144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy.
    Marcaccini AM; Meschiari CA; Zuardi LR; de Sousa TS; Taba M; Teofilo JM; Jacob-Ferreira AL; Tanus-Santos JE; Novaes AB; Gerlach RF
    J Clin Periodontol; 2010 Feb; 37(2):180-90. PubMed ID: 19995403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagenolytic fragments and active gelatinase complexes in periodontitis.
    Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
    J Periodontol; 2008 Sep; 79(9):1704-11. PubMed ID: 18771372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1.
    Tüter G; Kurtiş B; Serdar M; Yücel A; Ayhan E; Karaduman B; Ozcan G
    J Clin Periodontol; 2005 Sep; 32(9):1011-5. PubMed ID: 16104967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients.
    Alpagot T; Suzara V; Bhattacharyya M
    J Periodontal Res; 2006 Dec; 41(6):491-7. PubMed ID: 17076772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable periodontal healing of 1-wall infrabony defects after application of calcium phosphate cement wall alone or in combination with enamel matrix derivative: a pilot study with canine mandibles.
    Shirakata Y; Yoshimoto T; Goto H; Yonamine Y; Kadomatsu H; Miyamoto M; Nakamura T; Hayashi C; Izumi Y
    J Periodontol; 2007 May; 78(5):889-98. PubMed ID: 17470023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
    Xu L; Yu Z; Lee HM; Wolff MS; Golub LM; Sorsa T; Kuula H
    Acta Odontol Scand; 2008 Aug; 66(4):219-24. PubMed ID: 18615324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease.
    Biyikoğlu B; Buduneli N; Kardeşler L; Aksu K; Pitkala M; Sorsa T
    J Periodontol; 2009 Aug; 80(8):1307-14. PubMed ID: 19656031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid.
    Azmak N; Atilla G; Luoto H; Sorsa T
    J Periodontol; 2002 Jun; 73(6):608-15. PubMed ID: 12083533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis.
    Ertugrul AS; Dursun R; Dundar N; Avunduk MC; Hakki SS
    Arch Oral Biol; 2013 Jul; 58(7):843-52. PubMed ID: 23433942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome.
    Ullbro C; Crossner CG; Nederfors T; Parhar R; Al Mohanna F; Meikle MC; Reynolds JJ; Twetman S
    Acta Odontol Scand; 2004 Apr; 62(2):70-4. PubMed ID: 15198385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soft-tissue wound healing following periodontal surgery and Emdogain application.
    Hagenaars S; Louwerse PH; Timmerman MF; Van der Velden U; Van der Weijden GA
    J Clin Periodontol; 2004 Oct; 31(10):850-6. PubMed ID: 15367188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis.
    Gonçalves PF; Huang H; McAninley S; Alfant B; Harrison P; Aukhil I; Walker C; Shaddox LM
    J Periodontol; 2013 Dec; 84(12):1801-8. PubMed ID: 23537121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.